Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Odongpiny, Eva Agnes Laker
21  Ergebnisse:
Personensuche X
?
1

Patient experiences of switching from Efavirenz- to Doluteg..:

Twimukye, Adelline ; Laker, Miriam ; Odongpiny, Eva Agnes Laker...
BMC Infectious Diseases.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
2

Blood glucose outcomes of anti-retroviral therapy naïve Uga..:

Mulindwa, Frank ; Schwarz, Jean-Marc ; Brusselaers, Nele...
BMC Infectious Diseases.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Blood glucose trajectories and incidence of diabetes mellit..:

Mulindwa, Frank ; Castelnuovo, Barbara ; Brusselaers, Nele...
AIDS Research and Therapy.  20 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

High willingness to use injectable antiretroviral therapy a..:

Odongpiny, Eva Laker Agnes ; Cresswell, Fiona ; Arinaitwe, Arnold...
HIV Medicine.  23 (2022)  4 - p. 319-323 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Prevalence of overweight and obesity among adolescents livi..:

Nakatudde, Irene ; Katana, Elizabeth ; Agnes Odongpiny, Eva Laker...
AIDS Research and Therapy.  21 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

Dolutegravir use over 48 weeks is not associated with worse..:

Mulindwa, Frank ; Castelnuovo, Barbara ; Brusselaers, Nele...
AIDS Research and Therapy.  20 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
7

Two-drug regimens for the treatment of HIV in Africa:

Mambule, Ivan ; Norcross, Claire ; Achieng Ombajo, Loice...
The Lancet HIV.  11 (2024)  6 - p. e419-e426 , 2024
Link: https://doi.org/10.1016/..
 
?
8

The Potential Teratogenicity Alert for Women Conceiving on ..:

Laker, Eva Agnes Odongpiny ; Arinaitwe, Arnold ; Owarwo, Noela...
Drug Safety.  43 (2020)  11 - p. 1133-1140 , 2020
Link: https://doi.org/10.1007/..
 
?
9

An observational study in an urban Ugandan clinic comparing..:

Laker, Eva Agnes Odongpiny ; Nabaggala, Maria Sarah ; Kaimal, Arvind...
BMC Infectious Diseases.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
10

Patient experiences of switching from Efavirenz- to Doluteg..:

Twimukye, Adelline ; Laker, Miriam ; Odongpiny, Eva Agnes Laker...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590364/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Blood glucose trajectories and incidence of diabetes mellit..:

Mulindwa, Frank ; Castelnuovo, Barbara ; Brusselaers, Nele...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009965/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Efficacy and safety of dolutegravir or darunavir in combina..:

Paton, Nicholas I ; Musaazi, Joseph ; Kityo, Cissy...
The Lancet HIV.  9 (2022)  6 - p. e381-e393 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Dolutegravir use over 48 weeks is not associated with worse..:

Mulindwa, Frank ; Castelnuovo, Barbara ; Brusselaers, Nele...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492310/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

An observational study in an urban Ugandan clinic comparing..:

Eva Agnes Odongpiny Laker ; Maria Sarah Nabaggala ; Arvind Kaimal...
http://link.springer.com/article/10.1186/s12879-019-3907-5.  , 2019
Link: https://doi.org/10.1186/..
 
?
15

An observational study in an urban Ugandan clinic comparing..:

Laker, Eva Agnes Odongpiny ; Nabaggala, Maria Sarah ; Kaimal, Arvind...
https://www.repository.cam.ac.uk/handle/1810/296504.  , 2019
Link: https://www.repository.c..
 
1-15